Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $8.52 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 42.31.
Market Cap
8.52T
Revenue
4.59T
Profits
201.34B
PE Ratio
42.31
Profit Margin
4.39%
Dividend Yield
0.43%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.01T | -2.41% | 2,437,750 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 579.83B | 1.07% | 6,456,849 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 402.35B | 1.32% | 4,085,331 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 371.00B | 0.73% | 7,269,620 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 294.03B | -1.42% | 10,927,005 | 65.77B |
| 6 | NVS | Novartis AG | 280.78B | -0.55% | 1,178,040 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 280.26B | -1.94% | 2,393,906 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 197.32B | -0.18% | 14,799,175 | 50.57B |
| 9 | AMGN | Amgen Inc. | 191.70B | 0.32% | 2,730,115 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 174.42B | -1.33% | 2,389,702 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 155.93B | -0.22% | 5,215,939 | 29.74B |
| 12 | ABT | Abbott Laboratories | 153.59B | -1.64% | 13,786,296 | 45.13B |
| 13 | PFE | Pfizer Inc. | 149.38B | 0.15% | 38,772,946 | 63.32B |
| 14 | ISRG | Intuitive Surgical, Inc. | 145.58B | -0.45% | 1,777,295 | 10.58B |
| 15 | CVS | CVS Health Corporation | 130.09B | 1.47% | 11,178,458 | 405.62B |
| 16 | DHR | Danaher Corporation | 127.47B | -0.38% | 3,126,705 | 24.78B |
| 17 | SYK | Stryker Corporation | 119.69B | 2.15% | 3,182,341 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 116.66B | 0.40% | 7,840,636 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 112.92B | -0.03% | 924,127 | 12.22B |
| 20 | SNY | Sanofi | 106.43B | 0.32% | 1,559,053 | 54.60B |
| 21 | GSK | GSK plc | 106.31B | 0.34% | 3,805,959 | 43.29B |
| 22 | MDT | Medtronic plc | 102.97B | -0.16% | 7,692,356 | 36.36B |
| 23 | MCK | McKesson Corporation | 94.25B | -0.40% | 608,940 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 87.75B | 1.23% | 1,553,668 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 85.89B | 2.29% | 1,811,065 | 76.39B |
| 26 | CI | The Cigna Group | 78.83B | 1.07% | 1,324,124 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 69.72B | -0.55% | 16,761,904 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 62.28B | 0.11% | 717,782 | 14.92B |
| 29 | ARGX | argenx SE | 56.42B | -0.60% | 333,159 | 4.74B |
| 30 | COR | Cencora, Inc. | 54.80B | 0.07% | 1,061,931 | 328.68B |
| 31 | CAH | Cardinal Health, Inc. | 52.43B | 1.22% | 2,198,451 | 250.74B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 50.12B | 0.25% | 3,971,656 | 28.34B |
| 33 | EW | Edwards Lifesciences Corporation | 49.01B | -0.76% | 4,571,611 | 6.30B |
| 34 | MDLN | Medline Inc. | 48.09B | -1.40% | 12,484,267 | 29.14B |
| 35 | HUM | Humana Inc. | 45.53B | 2.86% | 980,207 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.24B | 0.53% | 516,571 | 4.45B |
| 37 | TEVA | Teva Pharmaceutical Industries Limited | 40.32B | 0.20% | 5,928,024 | 17.35B |
| 38 | BDX | Becton, Dickinson and Company | 40.30B | -0.75% | 1,966,917 | 22.23B |
| 39 | HLN | Haleon plc | 40.05B | 1.11% | 8,101,982 | 14.85B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.76B | -2.26% | 1,420,043 | 4.29B |
| 41 | A | Agilent Technologies, Inc. | 36.67B | 0.22% | 2,288,336 | 7.23B |
| 42 | WAT | Waters Corporation | 34.91B | -1.17% | 780,937 | 3.77B |
| 43 | ZTS | Zoetis Inc. | 33.36B | -2.25% | 6,641,927 | 9.53B |
| 44 | RVMD | Revolution Medicines, Inc. | 32.71B | 3.11% | 1,580,641 | - |
| 45 | ALC | Alcon Inc. | 32.57B | 0.51% | 1,242,436 | 10.63B |
| 46 | CNC | Centene Corporation | 32.19B | 2.60% | 4,784,414 | 178.33B |
| 47 | RPRX | Royalty Pharma plc | 31.60B | -0.76% | 3,185,482 | 2.44B |
| 48 | NTRA | Natera, Inc. | 30.37B | -3.27% | 806,591 | 2.50B |
| 49 | IQV | IQVIA Holdings Inc. | 30.29B | 0.22% | 1,254,283 | 16.63B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 29.65B | 1.04% | 3,174,962 | 20.98B |
| 51 | BIIB | Biogen Inc. | 29.53B | 0.05% | 837,285 | 9.94B |
| 52 | ONC | BeOne Medicines AG | 29.40B | 1.62% | 260,934 | 5.70B |
| 53 | DXCM | DexCom, Inc. | 29.08B | 0.16% | 4,773,768 | 4.82B |
| 54 | RMD | ResMed Inc. | 28.13B | 1.24% | 1,085,624 | 5.54B |
| 55 | VEEV | Veeva Systems Inc. | 25.92B | -1.24% | 1,909,101 | 3.32B |
| 56 | PHG | Koninklijke Philips N.V. | 25.14B | 1.34% | 1,032,777 | 20.34B |
| 57 | ILMN | Illumina, Inc. | 24.35B | -3.15% | 1,498,518 | 4.39B |
| 58 | WST | West Pharmaceutical Services, Inc. | 23.23B | -0.46% | 465,317 | 3.22B |
| 59 | UTHR | United Therapeutics Corporation | 23.17B | 0.10% | 451,820 | 3.17B |
| 60 | BNTX | BioNTech SE | 22.90B | 1.12% | 1,130,844 | 3.23B |
| 61 | MTD | Mettler-Toledo International Inc. | 22.86B | -0.86% | 116,119 | 4.09B |
| 62 | DGX | Quest Diagnostics Incorporated | 22.48B | -0.38% | 898,842 | 11.28B |
| 63 | LH | Labcorp Holdings Inc. | 21.83B | 0.34% | 483,382 | 14.14B |
| 64 | INCY | Incyte Corporation | 21.68B | 0.65% | 1,488,671 | 5.36B |
| 65 | ROIV | Roivant Sciences Ltd. | 21.61B | 1.04% | 5,305,983 | 8.26M |
| 66 | INSM | Insmed Incorporated | 21.21B | 1.17% | 4,524,714 | 819.56M |
| 67 | STE | STERIS plc | 20.23B | 0.16% | 628,347 | 5.94B |
| 68 | MRNA | Moderna, Inc. | 19.80B | 0.54% | 5,080,667 | 2.23B |
| 69 | VTRS | Viatris Inc. | 19.19B | 1.04% | 6,231,305 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 17.45B | 0.55% | 1,511,450 | 1.08B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 17.13B | 1.64% | 1,784,487 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.06B | -1.81% | 1,055,099 | 3.10B |
| 73 | GMAB | Genmab A/S | 15.40B | -0.73% | 1,113,721 | 3.90B |
| 74 | THC | Tenet Healthcare Corporation | 15.04B | 0.86% | 1,326,250 | 21.46B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.47B | -2.38% | 629,452 | 4.44B |
| 76 | SOLV | Solventum Corporation | 13.66B | -0.44% | 1,124,515 | 8.26B |
| 77 | ASND | Ascendis Pharma A/S | 13.54B | 1.14% | 405,008 | 998.25M |
| 78 | DVA | DaVita Inc. | 13.40B | 2.37% | 936,588 | 13.84B |
| 79 | EXEL | Exelixis, Inc. | 13.35B | -0.69% | 1,584,571 | 2.38B |
| 80 | MEDP | Medpace Holdings, Inc. | 13.35B | -1.63% | 297,334 | 2.68B |
| 81 | COO | The Cooper Companies, Inc. | 13.24B | 0.55% | 1,972,537 | 4.23B |
| 82 | BTSG | BrightSpring Health Services, Inc. | 13.17B | 0.24% | 4,012,184 | 13.65B |
| 83 | AXSM | Axsome Therapeutics, Inc. | 13.13B | 0.55% | 441,647 | 708.24M |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.08B | -1.11% | 1,545,533 | 579.96M |
| 85 | SNN | Smith & Nephew plc | 12.90B | -0.33% | 697,133 | 6.16B |
| 86 | PEN | Penumbra, Inc. | 12.54B | 0.12% | 514,479 | 1.45B |
| 87 | ALGN | Align Technology, Inc. | 12.52B | -0.95% | 574,465 | 4.10B |
| 88 | FMS | Fresenius Medical Care AG | 12.34B | 2.91% | 613,159 | 22.32B |
| 89 | IONS | Ionis Pharmaceuticals, Inc. | 12.11B | -0.74% | 1,964,867 | 1.06B |
| 90 | ELAN | Elanco Animal Health Incorporated | 12.07B | 0.50% | 4,512,112 | 4.89B |
| 91 | ICLR | ICON Public Limited Company | 11.19B | -2.49% | 703,865 | 8.25B |
| 92 | RDY | Dr. Reddy's Laboratories Limited | 11.16B | -0.45% | 1,173,616 | 3.58B |
| 93 | RVTY | Revvity, Inc. | 11.12B | -1.83% | 927,423 | 2.90B |
| 94 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.08B | 1.37% | 207,463 | 1.13B |
| 95 | GMED | Globus Medical, Inc. | 10.91B | -0.16% | 1,460,550 | 3.10B |
| 96 | SMMT | Summit Therapeutics Inc. | 10.87B | 7.11% | 9,878,229 | - |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.81B | 0.74% | 1,099,930 | 3.24B |
| 98 | BAX | Baxter International Inc. | 10.77B | 1.81% | 7,621,468 | 11.32B |
| 99 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.50B | 0.15% | 1,182,200 | 622.01M |
| 100 | MOH | Molina Healthcare, Inc. | 10.43B | 3.66% | 1,187,666 | 43.10B |
| 101 | PODD | Insulet Corporation | 10.37B | 0.34% | 992,588 | 2.90B |
| 102 | EHC | Encompass Health Corporation | 10.07B | -0.89% | 881,926 | 6.07B |
| 103 | NUVL | Nuvalent, Inc. | 9.74B | -0.16% | 7,237,349 | - |
| 104 | CYTK | Cytokinetics, Incorporated | 9.52B | 1.27% | 1,292,927 | 105.82M |
| 105 | KRYS | Krystal Biotech, Inc. | 9.37B | -1.11% | 313,480 | 417.30M |
| 106 | RGC | Regencell Bioscience Holdings Limited | 9.33B | -4.37% | 85,622 | - |
| 107 | HSIC | Henry Schein, Inc. | 9.26B | 1.25% | 1,089,034 | 13.38B |
| 108 | CRL | Charles River Laboratories International, Inc. | 9.03B | -0.29% | 493,938 | 4.03B |
| 109 | CORT | Corcept Therapeutics Incorporated | 8.90B | -0.41% | 718,967 | 769.10M |
| 110 | UHS | Universal Health Services, Inc. | 8.86B | 0.25% | 677,561 | 17.76B |
| 111 | ENSG | The Ensign Group, Inc. | 8.66B | 1.52% | 1,271,069 | 5.27B |
| 112 | TEM | Tempus AI, Inc. | 8.59B | -3.57% | 6,115,452 | 1.36B |
| 113 | OSCR | Oscar Health, Inc. | 8.51B | -2.25% | 6,046,267 | 13.30B |
| 114 | TECH | Bio-Techne Corporation | 8.45B | -0.04% | 2,558,198 | 1.21B |
| 115 | BRKR | Bruker Corporation | 8.26B | -1.72% | 2,355,917 | 3.46B |
| 116 | HALO | Halozyme Therapeutics, Inc. | 8.24B | -1.74% | 1,042,023 | 1.51B |
| 117 | ABVX | ABIVAX Société Anonyme | 7.85B | -4.28% | 1,164,026 | 5.67M |
| 118 | QGEN | Qiagen N.V. | 7.66B | -0.96% | 1,894,674 | 2.10B |
| 119 | BIO | Bio-Rad Laboratories, Inc. | 7.65B | -2.22% | 184,393 | 2.59B |
| 120 | ATR | AptarGroup, Inc. | 7.51B | 0.98% | 342,604 | 3.87B |
| 121 | GKOS | Glaukos Corporation | 7.44B | 2.05% | 707,981 | 551.35M |
| 122 | IBRX | ImmunityBio, Inc. | 7.44B | -1.39% | 8,816,047 | 140.98M |
| 123 | PRAX | Praxis Precision Medicines, Inc. | 7.43B | 7.50% | 423,159 | 7.46M |
| 124 | HQY | HealthEquity, Inc. | 7.39B | -0.70% | 717,263 | 1.34B |
| 125 | ALKS | Alkermes plc | 7.38B | -1.42% | 1,523,223 | 1.56B |
| 126 | RGEN | Repligen Corporation | 7.37B | -2.06% | 1,328,026 | 763.34M |
| 127 | KYMR | Kymera Therapeutics, Inc. | 7.09B | 3.91% | 625,177 | 51.48M |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 7.06B | -0.01% | 448,850 | 74.06M |
| 129 | TGTX | TG Therapeutics, Inc. | 7.02B | 3.06% | 2,548,895 | 700.35M |
| 130 | SYRE | Spyre Therapeutics, Inc. | 7.02B | 0.02% | 958,741 | - |
| 131 | IMVT | Immunovant, Inc. | 6.90B | 2.25% | 1,136,740 | - |
| 132 | PCVX | Vaxcyte, Inc. | 6.85B | 0.36% | 1,030,907 | - |
| 133 | LNTH | Lantheus Holdings, Inc. | 6.80B | 0.19% | 687,402 | 1.55B |
| 134 | LEGN | Legend Biotech Corporation | 6.66B | -1.13% | 1,700,342 | 1.14B |
| 135 | APGE | Apogee Therapeutics, Inc. | 6.62B | -1.31% | 1,302,759 | - |
| 136 | AVTR | Avantor, Inc. | 6.41B | -2.80% | 8,265,806 | 6.55B |
| 137 | GRFS | Grifols, S.A. | 6.40B | 2.00% | 480,282 | 8.58B |
| 138 | LQDA | Liquidia Corporation | 6.33B | -0.55% | 1,693,893 | 288.07M |
| 139 | PTCT | PTC Therapeutics, Inc. | 6.23B | 0.58% | 1,074,600 | 827.11M |
| 140 | HIMS | Hims & Hers Health, Inc. | 6.21B | -7.10% | 19,092,730 | 2.37B |
| 141 | CNTA | Centessa Pharmaceuticals plc | 6.15B | -0.13% | 1,322,753 | 15.00M |
| 142 | MIRM | Mirum Pharmaceuticals, Inc. | 6.07B | 0.04% | 553,577 | 569.61M |
| 143 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.06B | 0.82% | 554,372 | 217.17M |
| 144 | TFX | Teleflex Incorporated | 5.78B | 0.90% | 391,272 | 2.13B |
| 145 | PACS | PACS Group, Inc. | 5.74B | 4.37% | 959,246 | 5.43B |
| 146 | COGT | Cogent Biosciences, Inc. | 5.66B | 1.47% | 1,480,073 | - |
| 147 | CHE | Chemed Corporation | 5.54B | -0.37% | 154,841 | 2.54B |
| 148 | BLTE | Belite Bio, Inc | 5.44B | 0.96% | 154,909 | - |
| 149 | BLCO | Bausch + Lomb Corporation | 5.38B | -1.37% | 276,179 | 5.21B |
| 150 | SRRK | Scholar Rock Holding Corporation | 5.29B | -1.14% | 1,154,641 | - |
| 151 | CGON | CG Oncology, Inc. | 5.25B | 3.33% | 848,225 | 5.07M |
| 152 | AMRX | Amneal Pharmaceuticals, Inc. | 5.17B | -0.86% | 2,331,418 | 3.05B |
| 153 | LGND | Ligand Pharmaceuticals Incorporated | 5.12B | 0.38% | 247,085 | 274.48M |
| 154 | CAI | Caris Life Sciences, Inc. | 5.08B | -0.17% | 1,984,279 | 907.29M |
| 155 | HNGE | Hinge Health, Inc. | 5.06B | 0.91% | 1,222,840 | 646.34M |
| 156 | XENE | Xenon Pharmaceuticals Inc. | 5.04B | -0.17% | 704,211 | 7.50M |
| 157 | TVTX | Travere Therapeutics, Inc. | 4.84B | 6.40% | 2,388,400 | 536.20M |
| 158 | CRSP | CRISPR Therapeutics AG | 4.80B | -0.86% | 1,151,079 | 4.10M |
| 159 | TWST | Twist Bioscience Corporation | 4.74B | 2.86% | 2,612,033 | 409.48M |
| 160 | STVN | Stevanato Group S.p.A. | 4.66B | -1.21% | 538,772 | 1.39B |
| 161 | BLLN | BillionToOne, Inc. | 4.65B | 1.48% | 552,654 | 354.54M |
| 162 | SHC | Sotera Health Company | 4.62B | -1.22% | 1,449,989 | 1.19B |
| 163 | DNTH | Dianthus Therapeutics, Inc. | 4.49B | 7.35% | 1,381,056 | 1.34M |
| 164 | TNGX | Tango Therapeutics, Inc. | 4.48B | 3.76% | 10,056,709 | 56.99M |
| 165 | RDNT | RadNet, Inc. | 4.46B | -2.56% | 673,124 | 2.14B |
| 166 | ERAS | Erasca, Inc. | 4.37B | 0.29% | 2,078,145 | - |
| 167 | LIVN | LivaNova PLC | 4.36B | -0.69% | 725,970 | 1.43B |
| 168 | CELC | Celcuity Inc. | 4.32B | -1.05% | 1,532,971 | - |
| 169 | MMED | MiniMed Group, Inc. | 4.26B | -2.00% | 963,147 | 3.10B |
| 170 | ORKA | Oruka Therapeutics, Inc. | 4.22B | 2.07% | 781,475 | - |
| 171 | ALHC | Alignment Healthcare, Inc. | 4.08B | -2.42% | 4,409,034 | 4.26B |
| 172 | MANE | Veradermics, Incorporated | 4.01B | 1.77% | 260,393 | - |
| 173 | NVST | Envista Holdings Corporation | 4.00B | 0.41% | 2,491,909 | 2.81B |
| 174 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.99B | 0.60% | 362,760 | 754.05M |
| 175 | MMSI | Merit Medical Systems, Inc. | 3.97B | -0.54% | 514,940 | 1.54B |
| 176 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | -0.03% | 826,624 | 596.96M |
| 177 | VCYT | Veracyte, Inc. | 3.78B | -0.19% | 1,082,471 | 541.74M |
| 178 | EWTX | Edgewise Therapeutics, Inc. | 3.75B | 2.65% | 927,412 | - |
| 179 | IRTC | iRhythm Holdings, Inc. | 3.73B | 0.87% | 290,613 | 787.85M |
| 180 | DOCS | Doximity, Inc. | 3.66B | 0.10% | 2,286,865 | 644.86M |
| 181 | TXG | 10x Genomics, Inc. | 3.66B | -0.72% | 2,005,615 | 638.78M |
| 182 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.63B | 2.80% | 1,039,511 | 18.07M |
| 183 | ACAD | ACADIA Pharmaceuticals Inc. | 3.61B | -1.40% | 753,902 | 1.10B |
| 184 | CON | Concentra Group Holdings Parent, Inc. | 3.60B | 3.27% | 1,303,613 | 2.23B |
| 185 | WAY | Waystar Holding Corp. | 3.60B | 1.63% | 1,553,619 | 1.16B |
| 186 | NAMS | NewAmsterdam Pharma Company N.V. | 3.55B | 0.46% | 673,541 | 22.57M |
| 187 | HAE | Haemonetics Corporation | 3.55B | -2.05% | 1,198,318 | 1.33B |
| 188 | ICUI | ICU Medical, Inc. | 3.55B | -0.64% | 265,505 | 2.16B |
| 189 | OGN | Organon & Co. | 3.53B | -0.07% | 1,815,512 | 6.16B |
| 190 | DNLI | Denali Therapeutics Inc. | 3.44B | 3.04% | 2,189,073 | - |
| 191 | VKTX | Viking Therapeutics, Inc. | 3.34B | 0.49% | 1,177,603 | - |
| 192 | LFST | LifeStance Health Group, Inc. | 3.30B | -1.28% | 2,788,278 | 1.49B |
| 193 | OPCH | Option Care Health, Inc. | 3.26B | -0.10% | 3,055,125 | 5.67B |
| 194 | TLX | Telix Pharmaceuticals Limited | 3.26B | 1.16% | 386,780 | 803.79M |
| 195 | WRBY | Warby Parker Inc. | 3.25B | 2.32% | 2,215,908 | 890.57M |
| 196 | RLAY | Relay Therapeutics, Inc. | 3.23B | 4.00% | 1,770,054 | 10.68M |
| 197 | PBLS | Parabilis Medicines, Inc. | 3.22B | -10.06% | 1,035,847 | - |
| 198 | BKD | Brookdale Senior Living Inc. | 3.21B | 3.79% | 3,415,756 | 3.00B |
| 199 | ITGR | Integer Holdings Corporation | 3.09B | -1.22% | 225,214 | 1.86B |
| 200 | NHC | National HealthCare Corporation | 3.09B | 0.90% | 110,871 | 1.53B |
| 201 | ALMS | Alumis Inc. | 3.08B | 15.55% | 2,247,019 | 8.40M |
| 202 | GPCR | Structure Therapeutics Inc. | 3.05B | -0.85% | 545,883 | - |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.05B | -0.85% | 1,329,450 | 415.62M |
| 204 | DYN | Dyne Therapeutics, Inc. | 3.01B | 1.34% | 926,793 | - |
| 205 | RCUS | Arcus Biosciences, Inc. | 2.99B | 2.15% | 1,447,381 | 236.00M |
| 206 | PRVA | Privia Health Group, Inc. | 2.95B | 0.30% | 1,014,582 | 2.25B |
| 207 | BEAM | Beam Therapeutics Inc. | 2.89B | -1.29% | 1,588,353 | 164.01M |
| 208 | HTFL | HeartFlow, Inc. | 2.87B | 8.38% | 1,889,853 | 191.42M |
| 209 | ADPT | Adaptive Biotechnologies Corporation | 2.82B | -6.03% | 2,981,879 | 295.41M |
| 210 | ELVN | Enliven Therapeutics, Inc. | 2.81B | 14.30% | 6,145,866 | - |
| 211 | GRDN | Guardian Pharmacy Services, Inc. | 2.73B | 0.02% | 305,702 | 1.46B |
| 212 | DFTX | Definium Therapeutics, Inc. | 2.70B | 2.65% | 1,727,489 | - |
| 213 | TARS | Tarsus Pharmaceuticals, Inc. | 2.67B | -1.05% | 267,320 | 535.08M |
| 214 | IRON | Disc Medicine, Inc. | 2.60B | -0.13% | 184,471 | - |
| 215 | SUPN | Supernus Pharmaceuticals, Inc. | 2.58B | -2.52% | 825,356 | 776.83M |
| 216 | GRAL | GRAIL, Inc. | 2.57B | -0.52% | 344,056 | 156.12M |
| 217 | IDYA | IDEAYA Biosciences, Inc. | 2.55B | 0.49% | 617,010 | 225.27M |
| 218 | TMDX | TransMedics Group, Inc. | 2.52B | -0.92% | 659,678 | 635.89M |
| 219 | CLOV | Clover Health Investments, Corp. | 2.49B | -3.47% | 10,502,493 | 2.21B |
| 220 | VERA | Vera Therapeutics, Inc. | 2.46B | 1.81% | 901,690 | - |
| 221 | CLDX | Celldex Therapeutics, Inc. | 2.45B | 4.37% | 599,798 | 865.00K |
| 222 | KLRA | Kailera Therapeutics, Inc. | 2.45B | -3.33% | 411,682 | - |
| 223 | ESTA | Establishment Labs Holdings Inc. | 2.42B | -3.49% | 468,645 | 229.58M |
| 224 | RARE | Ultragenyx Pharmaceutical Inc. | 2.39B | 1.54% | 1,846,693 | 670.00M |
| 225 | AXGN | Axogen, Inc. | 2.29B | 1.51% | 1,553,330 | 238.11M |
| 226 | PBH | Prestige Consumer Healthcare Inc. | 2.27B | 0.53% | 543,192 | 1.09B |
| 227 | ACHC | Acadia Healthcare Company, Inc. | 2.26B | -1.17% | 1,926,320 | 3.37B |
| 228 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.21B | 2.35% | 2,394,656 | 885.72M |
| 229 | PHVS | Pharvaris N.V. | 2.14B | -4.60% | 180,165 | - |
| 230 | KOD | Kodiak Sciences Inc. | 2.13B | 0.26% | 630,072 | - |
| 231 | LMAT | LeMaitre Vascular, Inc. | 2.10B | -0.41% | 212,382 | 256.28M |
| 232 | PGNY | Progyny, Inc. | 2.09B | 3.82% | 1,290,135 | 1.29B |
| 233 | IMNM | Immunome, Inc. | 2.08B | 0.11% | 1,817,308 | 4.02M |
| 234 | SEM | Select Medical Holdings Corporation | 2.07B | - | 962,351 | 5.52B |
| 235 | NVCR | NovoCure Limited | 2.06B | 0.40% | 1,037,313 | 674.41M |
| 236 | AUPH | Aurinia Pharmaceuticals Inc. | 2.03B | -0.19% | 673,481 | 298.30M |
| 237 | XRAY | DENTSPLY SIRONA Inc. | 2.02B | -0.49% | 3,356,728 | 3.68B |
| 238 | TRVI | Trevi Therapeutics, Inc. | 2.02B | 5.57% | 1,513,353 | - |
| 239 | NKTR | Nektar Therapeutics | 2.01B | 0.29% | 534,201 | 55.63M |
| 240 | HRMY | Harmony Biosciences Holdings, Inc. | 1.99B | -2.10% | 693,305 | 899.11M |
| 241 | SGRY | Surgery Partners, Inc. | 1.98B | 2.48% | 1,305,273 | 3.34B |
| 242 | NEOG | Neogen Corporation | 1.98B | -1.62% | 1,228,389 | 870.56M |
| 243 | OCUL | Ocular Therapeutix, Inc. | 1.96B | 2.76% | 2,696,811 | 52.04M |
| 244 | MLYS | Mineralys Therapeutics, Inc. | 1.95B | -1.34% | 1,798,013 | - |
| 245 | MD | Pediatrix Medical Group, Inc. | 1.95B | 0.58% | 562,334 | 1.93B |
| 246 | ZLAB | Zai Lab Limited | 1.92B | -3.23% | 1,305,390 | 453.28M |
| 247 | ASTH | Astrana Health, Inc. | 1.91B | -3.09% | 520,004 | 3.53B |
| 248 | VCEL | Vericel Corporation | 1.91B | -2.99% | 364,973 | 292.09M |
| 249 | HCM | HUTCHMED (China) Limited | 1.90B | 2.62% | 31,364 | 548.51M |
| 250 | ADMA | ADMA Biologics, Inc. | 1.90B | -1.32% | 3,023,747 | 509.86M |
| 251 | LKFT | Lakefront Biotherapeutics NV | 1.90B | -0.09% | 91,349 | 1.20B |
| 252 | BHC | Bausch Health Companies Inc. | 1.89B | -1.94% | 1,853,444 | 10.53B |
| 253 | AGL | agilon health, inc. | 1.88B | -2.80% | 288,846 | 5.82B |
| 254 | STOK | Stoke Therapeutics, Inc. | 1.86B | 1.57% | 478,897 | 32.08M |
| 255 | RAPP | Rapport Therapeutics, Inc. | 1.84B | 9.06% | 255,556 | 20.00M |
| 256 | IOVA | Iovance Biotherapeutics, Inc. | 1.82B | 3.03% | 10,969,782 | 285.61M |
| 257 | UFPT | UFP Technologies, Inc. | 1.82B | -1.53% | 212,905 | 608.85M |
| 258 | VRDN | Viridian Therapeutics, Inc. | 1.81B | 1.30% | 1,247,301 | 70.92M |
| 259 | NBTX | Nanobiotix S.A. | 1.80B | -0.18% | 84,270 | 38.27M |
| 260 | MESO | Mesoblast Limited | 1.78B | -1.35% | 116,244 | 65.38M |
| 261 | WGS | GeneDx Holdings Corp. | 1.78B | -1.75% | 1,399,747 | 442.68M |
| 262 | NRIX | Nurix Therapeutics, Inc. | 1.75B | -0.18% | 2,562,914 | 71.78M |
| 263 | AGIO | Agios Pharmaceuticals, Inc. | 1.75B | 2.58% | 1,141,107 | 66.05M |
| 264 | QURE | uniQure N.V. | 1.74B | 2.80% | 836,695 | 18.09M |
| 265 | ANIP | ANI Pharmaceuticals, Inc. | 1.73B | 0.04% | 179,751 | 923.71M |
| 266 | OMCL | Omnicell, Inc. | 1.72B | 0.03% | 612,415 | 1.23B |
| 267 | NUVB | Nuvation Bio Inc. | 1.71B | 3.36% | 5,250,473 | 143.05M |
| 268 | ADUS | Addus HomeCare Corporation | 1.71B | 0.26% | 222,284 | 1.45B |
| 269 | BHVN | Biohaven Ltd. | 1.70B | -0.79% | 2,360,258 | - |
| 270 | NTLA | Intellia Therapeutics, Inc. | 1.69B | -1.94% | 10,223,440 | 66.09M |
| 271 | MBX | MBX Biosciences, Inc. | 1.69B | -4.67% | 2,156,477 | - |
| 272 | PLSE | Pulse Biosciences, Inc. | 1.69B | -9.37% | 403,120 | 751.00K |
| 273 | INVA | Innoviva, Inc. | 1.68B | 1.34% | 557,702 | 420.69M |
| 274 | RXRX | Recursion Pharmaceuticals, Inc. | 1.67B | - | 14,837,654 | 66.41M |
| 275 | ZYME | Zymeworks Inc. | 1.67B | -0.39% | 522,957 | 81.26M |
| 276 | TSHA | Taysha Gene Therapies, Inc. | 1.64B | 2.33% | 2,048,585 | 7.47M |
| 277 | AAPG | Ascentage Pharma Group International | 1.64B | 2.86% | 11,877 | 82.08M |
| 278 | SNDA | Sonida Senior Living, Inc. | 1.64B | -0.14% | 528,374 | 367.34M |
| 279 | ANAB | AnaptysBio, Inc. | 1.63B | 3.37% | 422,709 | 232.39M |
| 280 | CMPS | COMPASS Pathways plc | 1.63B | 5.87% | 2,515,634 | - |
| 281 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.62B | 4.89% | 1,692,008 | -665.00K |
| 282 | SION | Sionna Therapeutics, Inc. | 1.62B | -0.36% | 189,638 | - |
| 283 | SEPN | Septerna, Inc. | 1.62B | 5.64% | 475,859 | 72.26M |
| 284 | SNDX | Syndax Pharmaceuticals, Inc. | 1.62B | 1.90% | 1,048,610 | 217.17M |
| 285 | SRPT | Sarepta Therapeutics, Inc. | 1.62B | 2.07% | 2,270,569 | 2.18B |
| 286 | TYRA | Tyra Biosciences, Inc. | 1.61B | 5.55% | 1,013,844 | - |
| 287 | ABCL | AbCellera Biologics Inc. | 1.60B | -0.57% | 2,959,095 | 79.21M |
| 288 | GENB | Generate Biomedicines, Inc. | 1.59B | -4.25% | 688,396 | 30.30M |
| 289 | PGEN | Precigen, Inc. | 1.59B | -1.77% | 4,562,399 | 31.60M |
| 290 | PVLA | Palvella Therapeutics, Inc. | 1.56B | 2.28% | 360,810 | - |
| 291 | FTRE | Fortrea Holdings Inc. | 1.56B | -2.31% | 964,653 | 2.71B |
| 292 | AVAH | Aveanna Healthcare Holdings Inc. | 1.54B | 1.29% | 1,456,631 | 2.52B |
| 293 | GLUE | Monte Rosa Therapeutics, Inc. | 1.54B | 6.64% | 1,092,850 | 42.95M |
| 294 | HCSG | Healthcare Services Group, Inc. | 1.54B | 3.68% | 525,161 | 1.85B |
| 295 | ALMR | Alamar Biosciences, Inc. | 1.52B | -0.86% | 246,803 | 87.16M |
| 296 | PRGO | Perrigo Company plc | 1.52B | 0.83% | 3,243,182 | 4.18B |
| 297 | CAPR | Capricor Therapeutics, Inc. | 1.49B | 3.04% | 773,704 | 11.13M |
| 298 | IMCR | Immunocore Holdings plc | 1.47B | 1.22% | 276,830 | 412.81M |
| 299 | PRCT | PROCEPT BioRobotics Corporation | 1.46B | -7.17% | 1,378,191 | 322.02M |
| 300 | NVAX | Novavax, Inc. | 1.46B | -1.66% | 2,592,148 | 596.34M |
| 301 | ATRC | AtriCure, Inc. | 1.46B | 1.44% | 678,484 | 552.16M |
| 302 | SLS | SELLAS Life Sciences Group, Inc. | 1.46B | 1.03% | 4,089,538 | - |
| 303 | VIR | Vir Biotechnology, Inc. | 1.45B | 1.06% | 1,176,732 | 65.50M |
| 304 | NEO | NeoGenomics, Inc. | 1.45B | -2.79% | 1,480,991 | 745.97M |
| 305 | BFLY | Butterfly Network, Inc. | 1.45B | -2.46% | 5,770,071 | 102.92M |
| 306 | GHRS | GH Research PLC | 1.45B | 2.23% | 181,074 | - |
| 307 | URGN | UroGen Pharma Ltd. | 1.45B | 0.75% | 584,938 | 140.49M |
| 308 | ATAI | AtaiBeckley Inc. | 1.44B | 3.16% | 4,992,217 | 3.49M |
| 309 | BCAX | Bicara Therapeutics Inc. | 1.43B | 1.93% | 418,795 | - |
| 310 | AVBP | ArriVent BioPharma, Inc. | 1.42B | 1.13% | 448,157 | - |
| 311 | STAA | STAAR Surgical Company | 1.41B | -1.83% | 384,586 | 290.38M |
| 312 | ARDX | Ardelyx, Inc. | 1.41B | -1.73% | 2,628,414 | 427.68M |
| 313 | HROW | Harrow, Inc. | 1.40B | -0.03% | 740,769 | 268.68M |
| 314 | IART | Integra LifeSciences Holdings Corporation | 1.38B | 1.48% | 534,399 | 1.64B |
| 315 | MLTX | MoonLake Immunotherapeutics | 1.38B | 5.30% | 738,548 | - |
| 316 | INBX | Inhibrx Biosciences, Inc. | 1.35B | -1.43% | 263,337 | 1.30M |
| 317 | AHCO | AdaptHealth Corp. | 1.35B | 0.59% | 769,294 | 3.29B |
| 318 | ARDT | Ardent Health, Inc. | 1.34B | -3.31% | 487,620 | 6.43B |
| 319 | MAZE | Maze Therapeutics, Inc. | 1.34B | 0.25% | 596,578 | 20.00M |
| 320 | SVRA | Savara Inc. | 1.33B | -0.19% | 1,252,673 | - |
| 321 | TDOC | Teladoc Health, Inc. | 1.32B | 0.41% | 4,860,077 | 2.51B |
| 322 | ALVO | Alvotech | 1.30B | -1.18% | 533,765 | 562.04M |
| 323 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.29B | -4.41% | 1,675,461 | 204.73M |
| 324 | IMTX | Immatics N.V. | 1.28B | 3.53% | 376,663 | 43.00M |
| 325 | DMRA | Damora Therapeutics, Inc. | 1.28B | -2.72% | 207,152 | - |
| 326 | PAHC | Phibro Animal Health Corporation | 1.28B | 0.86% | 182,964 | 1.50B |
| 327 | BLFS | BioLife Solutions, Inc. | 1.28B | -1.88% | 695,437 | 101.66M |
| 328 | ATEC | Alphatec Holdings, Inc. | 1.27B | 1.85% | 1,766,641 | 787.08M |
| 329 | MPLT | MapLight Therapeutics, Inc. | 1.26B | -8.57% | 324,401 | - |
| 330 | AVLN | Avalyn Pharma Inc. | 1.26B | 7.16% | 286,484 | - |
| 331 | ENOV | Enovis Corporation | 1.25B | 3.22% | 907,673 | 2.28B |
| 332 | ZBIO | Zenas BioPharma, Inc. | 1.25B | 11.49% | 1,322,073 | 10.00M |
| 333 | INNV | InnovAge Holding Corp. | 1.24B | -0.44% | 359,108 | 949.17M |
| 334 | INSP | Inspire Medical Systems, Inc. | 1.23B | 0.61% | 1,047,455 | 915.25M |
| 335 | KMTS | Kestra Medical Technologies, Ltd. | 1.22B | 3.53% | 358,109 | 83.72M |
| 336 | AKTS | Aktis Oncology, Inc. | 1.21B | 12.69% | 847,590 | 8.28M |
| 337 | IRMD | IRADIMED CORPORATION | 1.20B | -2.82% | 175,213 | 86.28M |
| 338 | AMN | AMN Healthcare Services, Inc. | 1.19B | 0.03% | 740,506 | 3.42B |
| 339 | CDNA | CareDx, Inc. | 1.19B | -2.92% | 770,154 | 412.82M |
| 340 | XERS | Xeris Biopharma Holdings, Inc. | 1.17B | -2.02% | 1,635,957 | 314.85M |
| 341 | AVNS | Avanos Medical, Inc. | 1.17B | -0.08% | 360,456 | 715.90M |
| 342 | AHG | Akso Health Group | 1.15B | -2.19% | 8,416 | 14.84M |
| 343 | PNTG | The Pennant Group, Inc. | 1.14B | 0.21% | 320,801 | 1.02B |
| 344 | TNDM | Tandem Diabetes Care, Inc. | 1.14B | 5.06% | 1,925,471 | 1.03B |
| 345 | MNKD | MannKind Corporation | 1.13B | -2.40% | 3,844,283 | 360.78M |
| 346 | WVE | Wave Life Sciences Ltd. | 1.13B | 1.03% | 2,244,875 | 71.80M |
| 347 | COLL | Collegium Pharmaceutical, Inc. | 1.12B | 0.87% | 278,459 | 796.33M |
| 348 | COAG | Hemab Therapeutics Holdings, Inc. | 1.10B | -7.28% | 168,755 | - |
| 349 | EYPT | EyePoint, Inc. | 1.09B | 4.24% | 1,093,546 | 7.61M |
| 350 | SDGR | Schrödinger, Inc. | 1.08B | -1.03% | 863,938 | 254.91M |
| 351 | OPK | OPKO Health, Inc. | 1.07B | -2.07% | 1,763,710 | 581.12M |
| 352 | ABSI | Absci Corporation | 1.06B | 4.45% | 4,468,142 | 1.84M |
| 353 | CNMD | CONMED Corporation | 1.05B | 1.05% | 381,189 | 1.37B |
| 354 | AZTA | Azenta, Inc. | 1.04B | 0.58% | 585,081 | 596.48M |
| 355 | DBVT | DBV Technologies S.A. | 1.03B | 5.29% | 991,699 | 5.74M |
| 356 | OMDA | Omada Health, Inc. | 1.02B | -3.33% | 672,159 | 283.30M |
| 357 | CRON | Cronos Group Inc. | 1.01B | -2.55% | 884,118 | 159.54M |
| 358 | PSNL | Personalis, Inc. | 1.00B | 1.80% | 1,965,121 | 64.52M |
| 359 | CRVS | Corvus Pharmaceuticals, Inc. | 1.00B | 2.84% | 1,023,191 | - |
| 360 | USPH | U.S. Physical Therapy, Inc. | 997.74M | -0.35% | 146,352 | 787.69M |
| 361 | NUTX | Nutex Health Inc. | 993.67M | -1.78% | 86,974 | 879.95M |
| 362 | EVO | Evotec SE | 981.25M | - | 15,834 | 859.03M |
| 363 | AORT | Artivion, Inc. | 975.72M | -2.43% | 638,947 | 458.69M |
| 364 | SPRY | ARS Pharmaceuticals, Inc. | 969.20M | 1.77% | 1,328,324 | 98.99M |
| 365 | QDEL | QuidelOrtho Corporation | 963.54M | 0.60% | 1,179,503 | 2.66B |
| 366 | SPTX | Seaport Therapeutics, Inc. | 954.50M | 1.58% | 99,621 | - |
| 367 | LMRI | Lumexa Imaging Holdings, Inc. | 926.22M | 1.26% | 663,517 | 1.03B |
| 368 | XNCR | Xencor, Inc. | 914.17M | 1.99% | 591,563 | 97.36M |
| 369 | PHAR | Pharming Group N.V. | 911.33M | -0.58% | 6,849 | 369.49M |
| 370 | PCRX | Pacira BioSciences, Inc. | 904.61M | -1.58% | 371,247 | 734.86M |
| 371 | AVR | Anteris Technologies Global Corp. | 900.78M | -1.72% | 691,701 | 1.85M |
| 372 | JBIO | Jade Biosciences, Inc. | 899.90M | -5.72% | 1,046,551 | - |
| 373 | GDRX | GoodRx Holdings, Inc. | 897.49M | 0.76% | 673,632 | 787.89M |
| 374 | DRTS | Alpha Tau Medical Ltd. | 888.23M | 1.76% | 857,378 | - |
| 375 | MGTX | MeiraGTx Holdings plc | 888.13M | -0.10% | 465,357 | 79.76M |
| 376 | AMPH | Amphastar Pharmaceuticals, Inc. | 883.18M | -2.44% | 377,788 | 720.53M |
| 377 | TALK | Talkspace, Inc. | 872.74M | - | 1,029,416 | 238.37M |
| 378 | ETON | Eton Pharmaceuticals, Inc. | 865.32M | -1.62% | 206,786 | 86.93M |
| 379 | OLMA | Olema Pharmaceuticals, Inc. | 862.12M | 1.23% | 1,600,067 | - |
| 380 | TBPH | Theravance Biopharma, Inc. | 856.81M | 0.79% | 230,169 | 109.78M |
| 381 | ORIC | ORIC Pharmaceuticals, Inc. | 856.09M | 5.75% | 1,561,550 | - |
| 382 | LXRX | Lexicon Pharmaceuticals, Inc. | 852.86M | 1.59% | 2,994,423 | 69.64M |
| 383 | INMD | InMode Ltd. | 852.18M | -0.30% | 448,433 | 374.64M |
| 384 | CGEM | Cullinan Therapeutics, Inc. | 841.98M | 5.55% | 1,318,279 | - |
| 385 | ABUS | Arbutus Biopharma Corporation | 841.51M | -0.70% | 1,011,408 | 191.45M |
| 386 | JANX | Janux Therapeutics, Inc. | 826.95M | -0.73% | 860,404 | 13.73M |
| 387 | PHAT | Phathom Pharmaceuticals, Inc. | 823.69M | 0.97% | 554,282 | 204.89M |
| 388 | IVA | Inventiva S.A. | 822.46M | 1.32% | 1,009,393 | 7.94M |
| 389 | LBRX | LB Pharmaceuticals Inc | 814.99M | -0.42% | 158,396 | - |
| 390 | ESPR | Esperion Therapeutics, Inc. | 810.91M | - | 11,227,107 | 418.24M |
| 391 | CERT | Certara, Inc. | 808.94M | -1.33% | 3,267,325 | 419.75M |
| 392 | SANA | Sana Biotechnology, Inc. | 803.73M | -3.25% | 2,254,675 | - |
| 393 | KURA | Kura Oncology, Inc. | 803.41M | 2.14% | 1,295,139 | 71.64M |
| 394 | BIOA | BioAge Labs, Inc. | 801.93M | 9.67% | 436,870 | 10.32M |
| 395 | ODTX | Odyssey Therapeutics, Inc. | 797.24M | 0.54% | 250,394 | 2.98M |
| 396 | VOR | Vor Biopharma Inc. | 778.11M | 1.92% | 545,055 | - |
| 397 | AVTX | Avalo Therapeutics, Inc. | 775.87M | 7.97% | 1,120,496 | 59.00K |
| 398 | ANNX | Annexon, Inc. | 771.70M | 0.21% | 3,196,199 | - |
| 399 | HSTM | HealthStream, Inc. | 763.39M | -0.34% | 180,551 | 311.78M |
| 400 | ANRO | Alto Neuroscience, Inc. | 753.47M | 0.19% | 272,048 | - |
| 401 | ZVRA | Zevra Therapeutics, Inc. | 747.81M | -2.47% | 1,720,012 | 122.29M |
| 402 | GERN | Geron Corporation | 737.75M | 0.88% | 8,110,765 | 196.12M |
| 403 | REPL | Replimune Group, Inc. | 733.24M | 3.02% | 1,972,916 | - |
| 404 | EVMN | Evommune, Inc. | 714.24M | -4.16% | 462,653 | 10.00M |
| 405 | BVS | Bioventus Inc. | 710.88M | -1.96% | 463,192 | 576.30M |
| 406 | AURA | Aura Biosciences, Inc. | 707.02M | 3.22% | 959,144 | - |
| 407 | SLDB | Solid Biosciences Inc. | 702.93M | -1.11% | 1,664,863 | - |
| 408 | CBLL | CeriBell, Inc. | 700.80M | 1.76% | 209,722 | 95.07M |
| 409 | RLMD | Relmada Therapeutics, Inc. | 697.52M | 1.99% | 1,127,884 | - |
| 410 | CRMD | CorMedix Inc. | 685.67M | -2.46% | 969,813 | 400.05M |
| 411 | DSGN | Design Therapeutics, Inc. | 685.15M | 4.18% | 562,644 | - |
| 412 | NNNN | Anbio Biotechnology | 684.26M | -5.17% | 33,536 | 8.65M |
| 413 | SIBN | SI-BONE, Inc. | 683.87M | 1.85% | 216,588 | 206.22M |
| 414 | TENX | Tenax Therapeutics, Inc. | 675.92M | 6.99% | 1,767,799 | - |
| 415 | SSII | SS Innovations International, Inc. | 672.44M | -4.82% | 42,968 | 48.47M |
| 416 | OCS | Oculis Holding AG | 669.70M | 0.82% | 406,823 | 1.40M |
| 417 | GMRS | GMR Solutions Inc. | 667.04M | -4.34% | 579,998 | 5.83B |
| 418 | ALLO | Allogene Therapeutics, Inc. | 655.79M | 1.06% | 8,642,455 | 22.00K |
| 419 | CTMX | CytomX Therapeutics, Inc. | 655.29M | 1.01% | 2,050,204 | 35.54M |
| 420 | BBNX | Beta Bionics, Inc. | 647.48M | -1.09% | 1,328,637 | 110.24M |
| 421 | OMER | Omeros Corporation | 632.20M | -14.19% | 7,784,719 | 9.89M |
| 422 | CSTL | Castle Biosciences, Inc. | 627.83M | -1.48% | 154,634 | 339.92M |
| 423 | CADL | Candel Therapeutics, Inc. | 627.19M | 4.90% | 1,361,835 | - |
| 424 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 620.83M | 3.89% | 227,337 | - |
| 425 | TRAX | First Tracks Biotherapeutics, Inc. | 615.50M | 3.58% | 415,306 | - |
| 426 | SGP | SpyGlass Pharma, Inc. | 614.71M | 1.66% | 57,083 | - |
| 427 | RIGL | Rigel Pharmaceuticals, Inc. | 607.79M | 2.40% | 241,691 | 299.77M |
| 428 | ACRS | Aclaris Therapeutics, Inc. | 603.35M | -1.14% | 1,114,529 | 8.37M |
| 429 | IRWD | Ironwood Pharmaceuticals, Inc. | 600.84M | 0.55% | 1,868,654 | 361.51M |
| 430 | DRUG | Bright Minds Biosciences Inc. | 598.77M | -1.01% | 658,144 | - |
| 431 | CBIO | Crescent Biopharma, Inc. | 595.46M | -2.29% | 181,954 | 11.88M |
| 432 | TLRY | Tilray Brands, Inc. | 594.03M | -2.73% | 3,182,088 | 858.28M |
| 433 | TCMD | Tactile Systems Technology, Inc. | 593.46M | -0.15% | 107,373 | 343.52M |
| 434 | BWAY | BrainsWay Ltd. | 593.13M | -0.41% | 45,132 | 56.22M |
| 435 | IMMX | Immix Biopharma, Inc. | 589.73M | 4.32% | 1,106,335 | - |
| 436 | TECX | Tectonic Therapeutic, Inc. | 571.36M | 3.20% | 101,573 | - |
| 437 | ACHV | Achieve Life Sciences, Inc. | 566.68M | - | 1,172,804 | - |
| 438 | PHR | Phreesia, Inc. | 560.02M | 0.11% | 902,272 | 495.59M |
| 439 | CLYM | Climb Bio, Inc. | 546.47M | 4.86% | 858,855 | - |
| 440 | GYRE | Gyre Therapeutics, Inc. | 541.84M | -2.15% | 81,588 | 117.05M |
| 441 | EVH | Evolent Health, Inc. | 539.91M | 4.80% | 2,109,682 | 1.89B |
| 442 | MDXG | MiMedx Group, Inc. | 536.20M | -2.44% | 947,119 | 389.42M |
| 443 | NPCE | NeuroPace, Inc. | 533.23M | -1.26% | 83,997 | 99.53M |
| 444 | TOI | The Oncology Institute, Inc. | 530.91M | 3.51% | 1,251,585 | 545.76M |
| 445 | FLGT | Fulgent Genetics, Inc. | 530.52M | -0.53% | 218,770 | 320.35M |
| 446 | CTEV | Claritev Corporation | 526.61M | -3.56% | 127,959 | 978.76M |
| 447 | XOMA | XOMA Royalty Corporation | 524.09M | -0.02% | 129,383 | 48.56M |
| 448 | AQST | Aquestive Therapeutics, Inc. | 523.13M | -0.95% | 1,223,124 | 50.27M |
| 449 | DNA | Ginkgo Bioworks Holdings, Inc. | 515.41M | -1.38% | 697,079 | 151.40M |
| 450 | CERS | Cerus Corporation | 512.94M | -1.16% | 2,235,661 | 216.56M |
| 451 | CTKB | Cytek Biosciences, Inc. | 511.40M | -1.49% | 1,821,875 | 204.17M |
| 452 | ALT | Altimmune, Inc. | 507.58M | 0.77% | 2,145,369 | 36.00K |
| 453 | VRXA | VERAXA Biotech AG | 506.00M | -19.32% | 24,463 | - |
| 454 | ANGO | AngioDynamics, Inc. | 504.35M | 0.17% | 229,574 | 313.73M |
| 455 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 456 | VALN | Valneva SE | 501.95M | 1.23% | 24,774 | 180.25M |
| 457 | PRME | Prime Medicine, Inc. | 501.21M | -1.60% | 1,709,892 | 4.03M |
| 458 | PROK | ProKidney Corp. | 495.38M | -1.20% | 774,777 | 889.00K |
| 459 | CABA | Cabaletta Bio, Inc. | 490.79M | - | 2,915,534 | - |
| 460 | ARVN | Arvinas, Inc. | 489.07M | 6.91% | 858,387 | 89.40M |
| 461 | KYTX | Kyverna Therapeutics, Inc. | 487.57M | 2.35% | 646,616 | - |
| 462 | AGMB | AgomAb Therapeutics NV | 480.66M | -1.21% | 80,724 | - |
| 463 | STRO | Sutro Biopharma, Inc. | 477.23M | 8.76% | 148,276 | 99.61M |
| 464 | EIKN | Eikon Therapeutics, Inc. | 473.71M | 2.70% | 228,922 | - |
| 465 | SRTA | Strata Critical Medical, Inc. | 469.84M | -1.09% | 1,520,059 | 228.58M |
| 466 | VREX | Varex Imaging Corporation | 465.04M | 0.04% | 337,667 | 857.50M |
| 467 | FDMT | 4D Molecular Therapeutics, Inc. | 461.60M | -0.11% | 560,414 | 88.24M |
| 468 | NGNE | Neurogene Inc. | 459.84M | 0.34% | 112,530 | 925.00K |
| 469 | KIDS | OrthoPediatrics Corp. | 457.71M | -0.06% | 96,184 | 243.30M |
| 470 | ASMB | Assembly Biosciences, Inc. | 455.00M | 2.33% | 144,394 | 71.10M |
| 471 | CTNM | Contineum Therapeutics, Inc. | 446.39M | 0.67% | 109,471 | - |
| 472 | PRLD | Prelude Therapeutics Incorporated | 445.31M | 9.25% | 315,319 | 16.72M |
| 473 | EOLS | Evolus, Inc. | 443.20M | 3.38% | 635,579 | 301.79M |
| 474 | WEAV | Weave Communications, Inc. | 439.20M | 1.10% | 757,264 | 248.72M |
| 475 | PRTA | Prothena Corporation plc | 431.91M | -0.12% | 315,355 | 57.94M |
| 476 | CCCC | C4 Therapeutics, Inc. | 431.21M | 0.78% | 2,849,660 | 34.86M |
| 477 | KMDA | Kamada Ltd. | 429.92M | - | 25,813 | 181.68M |
| 478 | EBS | Emergent BioSolutions Inc. | 429.28M | -0.83% | 476,652 | 676.80M |
| 479 | OVID | Ovid Therapeutics Inc. | 429.27M | 4.07% | 2,061,823 | 7.12M |
| 480 | FBRX | Forte Biosciences, Inc. | 429.09M | 0.92% | 219,296 | - |
| 481 | NRC | NRC Health | 423.46M | -0.32% | 87,271 | 138.64M |
| 482 | CYH | Community Health Systems, Inc. | 422.61M | 2.30% | 1,296,692 | 12.29B |
| 483 | RZLT | Rezolute, Inc. | 417.87M | 3.63% | 1,312,012 | - |
| 484 | AUTL | Autolus Therapeutics plc | 415.18M | - | 1,019,732 | 92.62M |
| 485 | ARTV | Artiva Biotherapeutics, Inc. | 414.94M | 6.75% | 1,432,259 | 251.00K |
| 486 | ANL | Adlai Nortye Ltd. | 412.80M | 1.27% | 55,008 | 5.00M |
| 487 | OCGN | Ocugen, Inc. | 409.61M | -0.82% | 3,743,289 | 4.47M |
| 488 | MYGN | Myriad Genetics, Inc. | 408.96M | -6.48% | 1,192,435 | 829.00M |
| 489 | CCRN | Cross Country Healthcare, Inc. | 408.38M | -0.15% | 230,785 | 1.00B |
| 490 | MOBI | Mobia Medical, Inc. | 407.28M | -0.08% | 166,235 | 32.04M |
| 491 | PACB | Pacific Biosciences of California, Inc. | 406.89M | -2.96% | 4,980,872 | 160.03M |
| 492 | IPSC | Century Therapeutics, Inc. | 405.80M | 0.45% | 702,375 | 109.16M |
| 493 | INDP | Indaptus Therapeutics, Inc. | 405.41M | 0.28% | 588,556 | - |
| 494 | DCTH | Delcath Systems, Inc. | 404.59M | -0.42% | 300,509 | 90.44M |
| 495 | CLPT | ClearPoint Neuro, Inc. | 403.06M | -2.89% | 448,947 | 40.61M |
| 496 | VTVT | vTv Therapeutics Inc. | 402.56M | 2.69% | 60,731 | 36.84M |
| 497 | VMD | Viemed Healthcare, Inc. | 400.62M | 0.29% | 200,391 | 286.57M |
| 498 | MNPR | Monopar Therapeutics Inc. | 400.39M | 0.83% | 154,406 | - |
| 499 | SGMT | Sagimet Biosciences Inc. | 400.15M | 0.78% | 460,216 | - |
| 500 | EPRX | Eupraxia Pharmaceuticals Inc. | 395.37M | 0.17% | 140,222 | - |